NDC 16571-862 – Bupropion hydrochloride

Bupropion Hydrochloride 150 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug 2 recalls

Product NDC16571-862

Product details

Brand name
Bupropion hydrochloride
Generic name
Bupropion hydrochloride
Labeler
Rising Pharma Holdings, Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA211020
Marketed since
August 1, 2022
Listing expires
December 31, 2027
Pharmacologic class
Aminoketone

Active ingredients

Uses, dosage, side effects and warnings for Bupropion hydrochloride →

Package NDC codes (5)

Package NDCDescriptionSince
16571-862-0330 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-03)Aug 1, 2022
16571-862-0990 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-09)Aug 1, 2022
16571-862-101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-10)Aug 1, 2022
16571-862-12120 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-12)Jun 3, 2024
16571-862-50500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-50)Aug 1, 2022

Recalls mentioning this NDC

Other Bupropion hydrochloride products